JP2007502303A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502303A5
JP2007502303A5 JP2006523417A JP2006523417A JP2007502303A5 JP 2007502303 A5 JP2007502303 A5 JP 2007502303A5 JP 2006523417 A JP2006523417 A JP 2006523417A JP 2006523417 A JP2006523417 A JP 2006523417A JP 2007502303 A5 JP2007502303 A5 JP 2007502303A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
fatty acid
acid
acid salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006523417A
Other languages
English (en)
Japanese (ja)
Other versions
JP4880461B2 (ja
JP2007502303A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/026403 external-priority patent/WO2005016312A1/en
Publication of JP2007502303A publication Critical patent/JP2007502303A/ja
Publication of JP2007502303A5 publication Critical patent/JP2007502303A5/ja
Application granted granted Critical
Publication of JP4880461B2 publication Critical patent/JP4880461B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006523417A 2003-08-13 2004-08-13 治療薬用のマイクロ粒子脂肪酸塩固体製剤 Expired - Fee Related JP4880461B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49482103P 2003-08-13 2003-08-13
US60/494,821 2003-08-13
PCT/US2004/026403 WO2005016312A1 (en) 2003-08-13 2004-08-13 Micro-particle fatty acid salt solid dosage formulations for therapeutic agents

Publications (3)

Publication Number Publication Date
JP2007502303A JP2007502303A (ja) 2007-02-08
JP2007502303A5 true JP2007502303A5 (https=) 2007-09-27
JP4880461B2 JP4880461B2 (ja) 2012-02-22

Family

ID=34193244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523417A Expired - Fee Related JP4880461B2 (ja) 2003-08-13 2004-08-13 治療薬用のマイクロ粒子脂肪酸塩固体製剤

Country Status (12)

Country Link
US (1) US7635675B2 (https=)
EP (1) EP1660047B1 (https=)
JP (1) JP4880461B2 (https=)
KR (1) KR101152470B1 (https=)
CN (2) CN102552917A (https=)
AU (1) AU2004264958B2 (https=)
CA (1) CA2535013C (https=)
DK (1) DK1660047T3 (https=)
ES (1) ES2445947T3 (https=)
PL (1) PL1660047T3 (https=)
PT (1) PT1660047E (https=)
WO (1) WO2005016312A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090281023A9 (en) * 2001-06-04 2009-11-12 Nobex Corporation Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
RU2527893C2 (ru) * 2004-07-19 2014-09-10 Биокон Лимитед Инсулин-олигомерные конъюгаты, их препараты и применения
WO2007006320A1 (en) * 2005-07-12 2007-01-18 Sherine Hassan Abbas Helmy Drinkable oral insulin liquid and capsules
ES2546016T3 (es) * 2005-10-13 2015-09-17 Biocon Limited Procedimiento para la preparación de conjugados de insulina
RU2524150C2 (ru) 2006-09-22 2014-07-27 Ново Нордиск А/С Аналоги инсулина, устойчивые к протеазам
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー/エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
RU2453332C2 (ru) 2007-10-16 2012-06-20 Байокон Лимитид Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
RU2517135C2 (ru) * 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
EP2334335A1 (en) * 2008-09-19 2011-06-22 Nektar Therapeutics Polymer conjugates of cd-np peptides
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
CN103596584B (zh) 2011-06-15 2016-12-14 诺沃—诺迪斯克有限公司 多取代的胰岛素
CN104364260B (zh) 2012-04-11 2017-02-22 诺和诺德股份有限公司 胰岛素制剂
JP6499184B2 (ja) 2013-10-07 2019-04-10 ノヴォ ノルディスク アー/エス インスリン類似体の新規な誘導体
AR099569A1 (es) 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー/エス Glp-1アゴニスト及び腸溶コーティングを含む錠剤
WO2016119854A1 (en) * 2015-01-29 2016-08-04 Novo Nordisk A/S Pharmaceutical composition for oral insulin administration comprising a tablet core and a polyvinyl alcohol coating
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
PE20210857A1 (es) 2016-12-16 2021-05-18 Novo Nordisk As Composiciones farmaceuticas que contienen insulina

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US187536A (en) * 1877-02-20 Improvement in discharge-nozzles for graiw-eievators
US3957662A (en) * 1972-08-08 1976-05-18 Hoffmann-La Roche Inc. Pharmaceutical lubricants
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS597683B2 (ja) 1976-06-23 1984-02-20 山之内製薬株式会社 顆粒剤
JPS55153712A (en) 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production
JPS56131514A (en) 1980-03-17 1981-10-15 Nissan Chem Ind Ltd Ketoprofen composition for rectum administration
JPS5764610A (en) 1980-10-08 1982-04-19 Fujisawa Pharmaceut Co Ltd Pharmaceutical for rectal administration
US4310543A (en) 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
JPS5764609A (en) 1980-10-09 1982-04-19 Nissan Chem Ind Ltd Cyclophosphamide composition for rectal administration
JPS57158719A (en) 1981-03-24 1982-09-30 Fujisawa Pharmaceut Co Ltd Rectal administration pharmaceutical
JPS5813508A (ja) 1981-07-14 1983-01-26 Taiho Yakuhin Kogyo Kk ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物
JPS58206515A (ja) 1982-05-25 1983-12-01 Fujisawa Pharmaceut Co Ltd 硬カプセル剤
US4704284A (en) 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
JPS5951223A (ja) 1982-09-17 1984-03-24 Sumitomo Chem Co Ltd 製剤組成物
US4439420A (en) * 1982-11-16 1984-03-27 Ethicon, Inc. Absorbable hemostatic composition
JPS59148735A (ja) 1983-02-14 1984-08-25 Fujisawa Pharmaceut Co Ltd ユビデカレノン組成物
JPS59175433A (ja) 1983-03-24 1984-10-04 Kanegafuchi Chem Ind Co Ltd S−アデノシル−l−メチオニン含有組成物
JPS60146825A (ja) 1984-01-10 1985-08-02 Asahi Chem Ind Co Ltd 経口医薬製剤
JPS60214735A (ja) 1984-04-06 1985-10-28 Morishita Seiyaku Kk 脂肪酸の直腸投与組成物
JPS60218318A (ja) 1984-04-16 1985-11-01 Ss Pharmaceut Co Ltd 軟カプセル充填用組成物
JPS6112632A (ja) 1984-06-27 1986-01-21 Eisai Co Ltd 脂溶性薬剤含有組成物
JPS6176416A (ja) 1984-09-20 1986-04-18 Fujimoto Seiyaku Kk 活性型ビタミンd↓3誘導体のカプセル剤用組成物
JPS61233625A (ja) 1985-04-08 1986-10-17 Sanraku Inc γ−リノレン酸含有油脂組成物
NL8600050A (nl) 1986-01-13 1987-08-03 Sanico Nv Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van.
ZA87279B (en) 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
US5140021A (en) 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
JPS6317821A (ja) 1986-07-11 1988-01-25 Taisho Pharmaceut Co Ltd 矯味経口製剤
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
JPS63280017A (ja) 1987-05-13 1988-11-17 R P Shiila- Kk 軟カプセル用の皮膜組成物
JPS6419018A (en) 1987-07-14 1989-01-23 Nippon Oils & Fats Co Ltd Cholesterol depressing agent
US4900734A (en) 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
CA1321994C (en) 1987-10-28 1993-09-07 Reid Von Borstel Acylated uridine and cytidine and uses thereof
JPH01224315A (ja) 1988-03-04 1989-09-07 Green Cross Corp:The 医薬組成物
JP2677613B2 (ja) 1988-06-24 1997-11-17 エーザイ株式会社 ビタミンe又はその誘導体の吸収促進組成物
US4908210A (en) 1988-10-28 1990-03-13 Eastman Kodak Company Lactylic salt tablet formulations and tablets
JP2818220B2 (ja) 1988-11-04 1998-10-30 フロイント産業株式会社 食品用の含水有機溶剤抽出物含有組成物および医薬用の含水有機溶剤抽出物含有組成物、並びにそれらの製造方法
GB8904182D0 (en) 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
FI96169C (fi) 1989-07-10 1996-05-27 Eisai Co Ltd Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi
US5532002A (en) 1989-08-17 1996-07-02 Cortecs Limited Gelatin pharmaceutical formulations
JPH03200715A (ja) 1989-12-27 1991-09-02 Lion Corp 口腔用組成物
JP2896185B2 (ja) 1990-02-27 1999-05-31 東京田辺製薬株式会社 胆汁酸内用液剤およびその製造方法
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
WO1992021348A1 (en) 1991-06-03 1992-12-10 Merck Sharp & Dohme Limited Pharmaceutical formulations of a benzodiazepine
JPH08505367A (ja) 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
US5298643A (en) 1992-12-22 1994-03-29 Enzon, Inc. Aryl imidate activated polyalkylene oxides
US5349001A (en) 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5321095A (en) 1993-02-02 1994-06-14 Enzon, Inc. Azlactone activated polyalkylene oxides
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
US5681811A (en) 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
AU7113594A (en) * 1993-06-21 1995-01-17 Enzon, Inc. Site specific synthesis of conjugated peptides
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
FR2710535B1 (fr) 1993-09-30 1995-11-24 Gattefosse Ets Sa Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
GB9325395D0 (en) 1993-12-11 1994-02-16 Ciba Geigy Ag Compositions
JPH07215883A (ja) 1994-02-01 1995-08-15 Shiyugaa Redei:Kk 冷凍保存可能な高濃度ロイヤルゼリーソフトカプセル製剤
JP3429065B2 (ja) 1994-06-21 2003-07-22 サンスター株式会社 口腔用液体組成物
US6165976A (en) * 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
KR0167613B1 (ko) 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
US6057139A (en) * 1995-06-29 2000-05-02 Mcneil-Ppc, Inc. Preblend of microcrystalline cellulose and lactase for making tablets
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
EP0760237A1 (en) 1995-08-30 1997-03-05 Cipla Limited Oil-in-water microemulsions
FR2748209B1 (fr) 1996-05-06 1998-06-05 Adir Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs
SK285019B6 (sk) 1997-01-30 2006-04-06 Novartis Ag Tvrdá želatínová tobolka
US5900402A (en) 1997-05-29 1999-05-04 Enzon, Inc. Method of reducing side effects associated with administration of oxygen-carrying proteins
GB9717428D0 (en) 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
US6054480A (en) 1997-09-18 2000-04-25 Nectra, Inc. Fatty acids as a diet supplement
US5985263A (en) 1997-12-19 1999-11-16 Enzon, Inc. Substantially pure histidine-linked protein polymer conjugates
US5965119A (en) 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6214330B1 (en) 1998-07-13 2001-04-10 Enzon, Inc. Coumarin and related aromatic-based polymeric prodrugs
US6703381B1 (en) 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
JP2000095676A (ja) 1998-09-21 2000-04-04 Tokai Capsule Kk ビタミンb12含有ソフトカプセル剤
HK1043945B (zh) 1999-02-23 2005-02-08 株式会社柳韩洋行 含氯雷他定和伪麻黄碱的药物胶囊组合物
EP1156812A4 (en) * 1999-02-23 2004-09-29 Isis Pharmaceuticals Inc MULTIPARTICULAR FORMULATION
CN1167462C (zh) 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
JP4538858B2 (ja) * 1999-03-09 2010-09-08 日油株式会社 滑沢剤およびそれを用いた固形製剤
JP3278427B2 (ja) 1999-03-26 2002-04-30 有限会社ゴトーコーポレーション カプセル剤の製造方法
GB9907715D0 (en) 1999-04-01 1999-05-26 Scherer Corp R P Pharmaceutical compositions
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
TWI232761B (en) 2000-07-01 2005-05-21 Pharmaceutical Ind Tech & Dev Capsule preparation for oral administration and the preparation method thereof
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6858580B2 (en) 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6720002B2 (en) 2001-07-20 2004-04-13 R.P. Scherer Technologies, Inc. Antihistamine formulations for soft capsule dosage forms
KR100425755B1 (ko) 2001-08-27 2004-04-03 주식회사 원진신약 이트라코나졸을 함유하는 조성물 및 그 제조방법
US6770625B2 (en) * 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
GB2391473B (en) 2002-08-02 2004-07-07 Satishchandra Punambhai Patel Pharmaceutical compositions
WO2004047871A2 (en) 2002-11-26 2004-06-10 Nobex Corporation Modified naturetic compounds, conjugates, and uses thereof
US20040115226A1 (en) 2002-12-12 2004-06-17 Wenji Li Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
KR100525234B1 (ko) 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
WO2005004919A2 (en) 2003-07-02 2005-01-20 Eurand, Inc. Extended release systems for macrolide antibiotics
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
WO2005089714A1 (ja) 2004-03-24 2005-09-29 Takeda Pharmaceutical Company Limited エマルション安定化製剤
CA2595116A1 (en) 2004-04-28 2005-11-10 Procarrier, Inc. Oral formulation for delivery of poorly absorbed drugs
WO2005115341A2 (en) 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery

Similar Documents

Publication Publication Date Title
JP2007502303A5 (https=)
TWI829687B (zh) 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物
JP5841708B2 (ja) 表面被覆微粒子の医薬組成物
JP2023166021A (ja) インスリン分泌促進性ペプチドの懸濁製剤及び使用
US20190022228A1 (en) Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
EP2060268A1 (en) Pharmaceutical compositions for pulmonary or nasal delivery of peptides
JP2008530070A (ja) 薬物の経粘膜投与に有用な新規な医薬組成物
JP6040231B2 (ja) ペプチド−ナノ粒子の組合せおよびそれを組み込んだ送達システム
JP2006249099A (ja) 持続放出特性を有する吸入用粒子
JP2009019047A (ja) 大治療質量エアロゾルの高度に効率的な送達
JP2011519867A5 (https=)
JPH05508616A (ja) 治療用エアロゾル剤
TW200529869A (en) Delivery system for drug and cell therapy
CN102686741A (zh) 基本稳态药物递送的快速建立和/或终止
JP2003513031A (ja) 改良された分散性を有する乾燥粉末組成物
JP4880461B2 (ja) 治療薬用のマイクロ粒子脂肪酸塩固体製剤
KR102849595B1 (ko) 안정성이 증진된 지질 기반 나노입자
WO2008025425A9 (fr) Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant
US20210169815A1 (en) Process for the manufacture of pharmaceutical compositions
JP2021167316A (ja) 活性剤の送達のための乾燥剤を含む経口製剤
EP2402003A3 (en) Diclofenac formulations and methods of use
WO2002015876A2 (en) Amorphous carrier materials for drug delivery
WO2015162195A1 (en) Fatty acid acylated amino acids for oral peptide delivery
WO1998009645A1 (en) Peptide-containing drug compositions for oral administration
WO2004078211A1 (ja) 粉末経鼻投与製剤